Insomnia symptoms might affect about 60% of the Italian population. Insomnia is a “24 hours syndrome” and a risk factor for medical and mental disorders. It should always be assessed and treated in the clinical practice. Cognitive Behavioral Therapy for Insomnia is the first line treatment but its availability in Italy is scarce. Pharmacological options in Italy are: melatonin 2 mg prolonged release that should be the first choice in subjects ≥55 years old and used until 13 weeks; and for a short term use (≤4 weeks) Z-drugs or short-acting benzodiazepines (in subjects <65 years old) or a sedating antidepressant.

Evaluation and management of insomnia in clinical practice and in the time of CoViD-19 in Italy: Expert consensus and task-force recommendations from five scientific societies

Aguglia E.;Amore M.;Grassi L.;
2020-01-01

Abstract

Insomnia symptoms might affect about 60% of the Italian population. Insomnia is a “24 hours syndrome” and a risk factor for medical and mental disorders. It should always be assessed and treated in the clinical practice. Cognitive Behavioral Therapy for Insomnia is the first line treatment but its availability in Italy is scarce. Pharmacological options in Italy are: melatonin 2 mg prolonged release that should be the first choice in subjects ≥55 years old and used until 13 weeks; and for a short term use (≤4 weeks) Z-drugs or short-acting benzodiazepines (in subjects <65 years old) or a sedating antidepressant.
2020
PAROLE CHIAVE: insonnia
Pratica clinica
Raccomandazioni degli esperti
Sonno e CoViD-19
Trattamento
Valutazione
Aged
Antidepressive Agents
COVID-19
Cognitive Behavioral Therapy
GABA Agonists
Humans
Hypnotics and Sedatives
Italy
Middle Aged
Receptors, Melatonin
Sleep Aids, Pharmaceutical
Sleep Initiation and Maintenance Disorders
Societies, Scientific
Consensus
Epidemics
SARS-CoV-2
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/505562
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact